Healthcare -
Biotechnology - NASDAQ - US
$ 1.115
-2.19 %
$ 147 M
Market Cap
-0.4
P/E
RAPT - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RAPT - RAPT Therapeutics, Inc.
104 M
LAST VALUE
81.11%
2 YEAR CAGR
99.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR